GFAP and early-onset autosomal dominant Alzheimer disease: Significantly, GFAP-VIVIT expression led to improved cognitive and synaptic functions, reduced glial activation and lower amyloid levels, thereby confirming the important role of astrocytes in Alzheimer’s disease [62].